Document is current

Article History

Received: 9 May 2024

Revised: 28 September 2024

Accepted: 1 November 2024

First Online: 21 November 2024

Declarations

:

: H.K. received honoraria or lecture fees from Bristol Myers Squibb, AbbVie GK, Asahi Kasei Pharma, AstraZeneca K.K., Beckton Dickinson K.K., Chugai Pharmaceutical Co., Ltd., GlaxoSmithKline K.K., Janssen Pharmaceutical K.K., Japan Blood Products Organization, Kissei Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Nippon Shinyaku Co., Ltd., Novartis Pharma K.K., Novo Nordisk Pharma Japan, Ono Pharmaceutical Co., Ltd., Sanofi K.K, and Takeda Pharmaceutical Co., Ltd. H.Iw. received honoraria or lecture fees from Astra Zeneca, AbbVie, Ono Pharmaceuticals, Janssen Pharmaceuticals, Sanofi, Daiichi Sankyo, Chugai Pharmaceuticals, and Takeda Pharmaceuticals; manuscript fees for promotional materials from SymBio Pharmaceuticals; and research funds for medical research from Kyowa Kirin. H.Ii. received honoraria or lecture fees from Novartis, Janssen Pharmaceuticals, Takeda Pharmaceuticals, Chugai Pharmaceuticals, Sanofi, Otsuka Pharmaceuticals, and AbbVie; and research funds for medical research from Nippon Kayaku and Chugai Pharmaceuticals. T.J. received honoraria or lecture fees from Eisai; and research funds for medical research from Bristol Myers Squibb. Y.M. received honoraria or lecture fees from Nippon Shinyaku; and a subsidy/donation from Eisai for presenting academic courses. Y.N. received research funds for medical research from Astellas Pharma, AbbVie, Celgene, Novartis Pharma, and Bristol Myers Squibb. K.O. has received research funds for medical research from Celgene. T.S. received honoraria or lecture fees from Alexion Pharmaceuticals, Novartis Pharma, Kyowa Kirin, Chugai Pharmaceuticals, and Bristol Myers Squibb. Y.T. received honoraria or lecture fees from Janssen Pharmaceuticals, Sanofi, and Chugai Pharmaceuticals. K.U. received honoraria or lecture fees from Novartis Pharma; and research funds for medical research from Astellas Pharma, AbbVie, Ono Pharmaceutical, Chugai Pharmaceutical, Bristol Myers Squibb, and Otsuka Pharmaceuticals. H.Y. owns stock or options in Bristol Myers Squibb and Merck, and is an employee of Bristol Myers Squibb. J.H. is an employee of Bristol Myers Squibb. S.M. owns stock or options in, and is an employee of, Bristol Myers Squibb. M.N. owns stock or options in, and is an employee of, Bristol Myers Squibb. M.S. is an employee of Bristol Myers Squibb. K.M. received research funds for medical research from Janssen Pharmaceutical, Bristol Myers Squibb, and Sanofi. T.F., A.S., S.K., K.S., and A.Y. have no conflicts of interest to disclose.